Cholinergic agonists increase intracellular calcium concentration in frog vestibular hair cells.
Acetylcholine (ACh) is usually considered to be the neurotransmitter of the efferent vestibular system. The nature and the localization of cholinergic receptors have been investigated on frog isolated vestibular hair cells (VHCs), by measuring variations of intracellular calcium concentration ([Ca2+]i), using calcium sensitive dye fura-2. Focal iontophoretic ACh (1 M, 300 nA.40 ms) application induced a rapid increase in [Ca2+]i, reaching a peak in 20 s and representing about 5-fold the resting level (from 61 +/- 6 to 320 +/- 26 nM). Applications of muscarinic agonists as methacholine and carbachol induced weaker calcium responses (from 78 +/- 25 to 238 +/- 53 nM) than the one obtained with ACh applications. These muscarinic agonists were efficient only in precise zones. Desensitization of muscarinic receptors to successive stimulations was significant. Perfusion of nicotine or 1,1-dimethyl-4-phenyl-piperazinium (DMPP), a nicotinic agonist, induced an increase in [Ca2+]i only in some cells (4/28 with DMPP). These results indicated the presence of cholinergic receptors on frog VHCs: muscarinic receptors were more responsive than nicotinic receptors. Presence of muscarinic and nicotinic receptors in the membrane of VHCs could indicate different modulations of VHCs activity mediated by [Ca2+]i and involving an efferent control which represents a central regulation of the vestibular afferent message.
Ohtani
M
M
Laboratoire de Neurophysiologie Sensorielle, Université de Montpellier II, France.
Devau
G
G
Lehouelleur
J
J
Sans
A
A
D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D018679:Cholinergic Agonists; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D016257:Fura-2 / Q000737:chemistry / Q000378:metabolism; D006198:Hair Cells, Auditory / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D007478:Iontophoresis; D016210:Methacholine Chloride / Q000494:pharmacology; D018721:Muscarinic Agonists; D009538:Nicotine / Q000494:pharmacology; D018722:Nicotinic Agonists; D011893:Rana esculenta; D011950:Receptors, Cholinergic / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000378:metabolism; D014722:Vestibule, Labyrinth / Q000166:cytology / Q000187:drug effects*
D018679:Cholinergic Agonists; D018721:Muscarinic Agonists; D018722:Nicotinic Agonists; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D011978:Receptors, Nicotinic; D016210:Methacholine Chloride; D004246:Dimethylphenylpiperazinium Iodide; D009538:Nicotine; D002217:Carbachol; D000109:Acetylcholine; D002118:Calcium; D016257:Fura-2